HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotherapies for non-small-cell lung cancer and mesothelioma.

Abstract
Non-small-cell lung cancer and mesothelioma are thoracic malignancies, which in their advanced stages are incurable and have poor prognosis. Advances in our understanding of immune responses to tumours, tumour immunosuppression mechanisms, and tumour-specific shared antigens enabled successful early clinical trials of several specific and non-specific immunotherapies. For non-small-cell lung cancer, phase 3 clinical trial results of Toll-like receptor agonists show little promise. However, ongoing phase 3 trials are assessing melanoma-associated antigen A3 vaccine, liposomal BLP25, belagenpumatucel-L, and talactoferrin. In mesothelioma, immunotherapies being investigated include dendritic cell-based and Listeria-based vaccines, and allogeneic tumour cell and WT1 analogue peptide vaccines. Selection of appropriate patients and disease stages for immunotherapy, measurement of tumour-specific immune responses, and understanding the association between immune and clinical responses are some of the major challenges for the development of immunotherapies for these malignancies.
AuthorsAnish Thomas, Raffit Hassan
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 13 Issue 7 Pg. e301-10 (Jul 2012) ISSN: 1474-5488 [Electronic] England
PMID22748269 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Review)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Antigens, Neoplasm
  • CTLA-4 Antigen
  • GPI-Linked Proteins
  • MAGEA3 protein, human
  • Neoplasm Proteins
  • Toll-Like Receptors
  • WT1 Proteins
  • Mesothelin
Topics
  • Antigens, Neoplasm (immunology)
  • CTLA-4 Antigen (antagonists & inhibitors)
  • Carcinoma, Non-Small-Cell Lung (therapy)
  • Dendritic Cells (immunology)
  • GPI-Linked Proteins (immunology)
  • Humans
  • Immunotherapy (methods)
  • Lung Neoplasms (therapy)
  • Mesothelin
  • Mesothelioma (therapy)
  • Neoplasm Proteins (immunology)
  • Toll-Like Receptors (agonists)
  • WT1 Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: